Betahistine dihydrochloride
99%
- Product Code: 110678
Alias:
Betahistine Hydrochloride
CAS:
5579-84-0
| Molecular Weight: | 209.12 g./mol | Molecular Formula: | C₈H₁₂N₂₂HCl |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00012813 | |
| Melting Point: | 150-154 °C | Boiling Point: | |
| Density: | Storage Condition: | room temperature |
Product Description:
Betahistine dihydrochloride is primarily used in the treatment of Ménière's disease, a disorder of the inner ear that can lead to dizziness, hearing loss, and tinnitus. It works by improving blood flow in the inner ear, which helps to reduce the severity and frequency of vertigo attacks. Additionally, it can alleviate symptoms like nausea and vomiting associated with the condition. The medication is also sometimes prescribed for other balance disorders or vertigo-related conditions. It is typically administered orally in tablet form and is often part of a long-term management plan for chronic ear-related issues.
Product Specification:
| Test | Specification |
|---|---|
| Loss On Drying | 0-0.01 |
| Melting Point | 150-154 |
| Purity (Neutralization Titration) | 99-100 |
| Solubility In Methanol | Very Faint Turbidity |
| Appearance | White To Yellow Powder |
| Infrared Spectrum | Conforms To Structure |
| Solubility | Colorless Clear (50Mg/Ml In Water) |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $32.64 |
+
-
|
| 5.000 | 10-20 days | $101.85 |
+
-
|
| 25.000 | 10-20 days | $382.25 |
+
-
|
| 100.000 | 10-20 days | $1,151.47 |
+
-
|
Betahistine dihydrochloride
Betahistine dihydrochloride is primarily used in the treatment of Ménière's disease, a disorder of the inner ear that can lead to dizziness, hearing loss, and tinnitus. It works by improving blood flow in the inner ear, which helps to reduce the severity and frequency of vertigo attacks. Additionally, it can alleviate symptoms like nausea and vomiting associated with the condition. The medication is also sometimes prescribed for other balance disorders or vertigo-related conditions. It is typically administered orally in tablet form and is often part of a long-term management plan for chronic ear-related issues.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :